RenalGuard Solutions

RenalGuard Solutions, Inc. is a privately held medical technology company located in Milford, Massachusetts. With a team of four employees, the company focuses on developing innovative technologies for the cardiac and vascular markets. RenalGuard Solutions specializes in the development and commercialization of medical devices aimed at preventing contrast-induced nephropathy (CIN). Their flagship product, RenalGuard®, is a system designed to automate matched fluid replacement during medical procedures, minimizing fluid imbalances and reducing the risk of CIN in at-risk patients. RenalGuard® has already received approval for sale in the European Union for general fluid balancing and has demonstrated effectiveness in preventing CIN through two investigator-sponsored European studies. The company is currently conducting a pivotal trial in the United States to obtain FDA approval for RenalGuard®. The RenalGuard System™ comprises a closed loop, software-controlled console and single-use sets, providing physicians and nurses with a user-friendly platform for automated fluid management. For inquiries or further information about RenalGuard Solutions and their products, please visit their website at renalguard.com.